Dehydroepiandrosterone treatment of women with mild-to-moderate systemic lupus erythematosus: A multicenter randomized, double-blind, placebo-controlled trial-Reference-Cited by-同舟云学术

Dehydroepiandrosterone treatment of women with mild-to-moderate systemic lupus erythematosus: A multicenter randomized, double-blind, placebo-controlled trial

Published:2002-11 Issue:11 Volume:46 Page:2924-2927
ISSN:0004-3591
Container-title:Arthritis & Rheumatism
language:en
Short-container-title:Arthritis & Rheumatism

Author:

Chang Deh-Ming,Lan Joung-Liang,Lin Hsiao-Yi,Luo Shue-Fen

Publisher

Wiley

Subject

Pharmacology (medical),Immunology,Rheumatology,Immunology and Allergy

Reference14 articles.

1. Conversion of dehydroepiandrosterone to downstream steroid hormones in macrophages

2. Low plasma androgens in women with systemic lupus erythematosus

3. Replacement therapy with DHEA plus corticosteroids in patients with chronic inflammatory diseases – substitutes of adrenal and sex hormones

4. Prevention of autoantibody formation and prolonged survival in New Zealand black/New Zealand white F1 mice fed dehydroisoandrosterone.

5. The 1982 revised criteria for the classification of systemic lupus erythematosus

Cited by 135 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Leveraging Lymphatic System Targeting in Systemic Lupus Erythematosus for Improved Clinical Outcomes;Pharmacological Reviews;2023-12-13

2. Advances in the management of systemic lupus erythematosus;BMJ;2023-10-26

3. Characteristics of steroid hormones in systemic lupus erythematosus revealed by GC/MS-based metabolic profiling;Frontiers in Endocrinology;2023-07-27

4. Sex and gender influence on immunity and autoimmunity;Frontiers in Immunology;2023-05-26

5. Fighting Fatigue in Systemic Lupus Erythematosus: Experience of Dehydroepiandrosterone on Clinical Parameters and Patient-Reported Outcomes;Journal of Clinical Medicine;2022-09-08